The critically ill patient with cancer - Indications for intensive care unit admission and outcomes

Journal of B.U.ON.

Volumn 13, Issue 4, 2008, Pages 469-478

  Markou, Nikolaos ^a,b   Demopoulou, E ^a   Myrianthefs, P ^a  

^a KAT HOSPITAL   (Greece)

^b ICU at KAT Hospital ^*  (Greece)

Author keywords

Cancer; Critical illness; ICU admission; Outcome

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE KIDNEY FAILURE; ACUTE RESPIRATORY FAILURE; ARTIFICIAL VENTILATION; BENEFICENCE; CANCER CHEMOTHERAPY; CARDIOPULMONARY ARREST; CLINICAL DECISION MAKING; COMORBIDITY; CRITICALLY ILL PATIENT; DRUG INDICATION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LONG TERM CARE; LUNG SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; NEGATIVE PRESSURE VENTILATION; PROGNOSIS; RENAL REPLACEMENT THERAPY; RESPIRATORY TRACT INTUBATION; RESUSCITATION; REVIEW; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE; TERMINAL CARE;

CARDIOPULMONARY RESUSCITATION; CRITICAL ILLNESS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTENSIVE CARE UNITS; KIDNEY FAILURE, ACUTE; NEOPLASMS; PATIENT ADMISSION; SEPSIS;

EID: 58149328752     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (112)

1. Brenner H. Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 2002; 360: 1131-1135.
2. Peters SG. Intensive care or end-of-life care for critically ill patients? Crit Care Med 2005; 33: 678-679.
3. Azoulay E, Afessa B. The intensive care support of patients with malignancy: do everything that can be done. Intensive Care Med 2006; 32: 3-5.
4. Task Force of the American College of Critical Care Medicine, Society of Intensive Care Medicine. Guidelines for intensive care admission discharge and triage. Crit Care Med 1999; 27: 633-638.
5. Kress JP, Christenson J, Pohlman AS, Linkin DR, Hall JB. Outcomes of critically ill cancer patients in a university hospital setting. Am J Respir Crit Care Med 1999; 160: 1957-1961.
6. Staudinger T, Stoiser B, Mullner M et al. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 2000; 28: 1322-1328.
7. Zarén B, Bergström R. Survival of intensive care patients. I: Prognostic factors from the patient's medical history. Acta Anaesthesiol Scand 1988; 32: 93-100.
8. Zarén B, Bergström R. Survival of intensive care patients. II: Outcome prediction 1 hour after admission. Acta Anaesthesiol Scand 1988; 32: 101-107.
9. Dragsted L, Qvist J. Outcome from intensive care. I. A 5-year study of 1308 patients: methodology and patient population. Eur J Anaesthesiol 1989; 6: 23-37.
10. Dragsted L, Qvist J, Madsen M. Outcome from intensive care. II. A 5-year study of 1308 patients: short-term outcome. Eur J Anaesthesiol 1989; 6: 131-144.
11. Kongsgaard UE, Meidell NK. Mechanical ventilation in critically ill cancer patients: outcome and utilisation of resources. Support Care Cancer 1999; 7: 95-99.
12. Niskanen M, Kari A, Halonen P. Five-year survival after intensive care-comparison of 12,180 patients with the general population. Finnish ICU Study Group. Crit Care Med 1996; 24: 1962-1967.
13. Schapira DV, Studnicki J, Bradham DD, Wolff P, Jarrett A. Intensive care survival and expense of treating critically ill cancer patients. JAMA 1993; 269: 783-796.
14. Lloyd-Thomas AR, Dhaliwal HS, Lister TA, Hinds CJ. Intensive therapy for life-threatening medical complications of haematological malignancy. Intensive Care Med 1986; 12: 317-324.
15. Crawford SW, Schwartz DA, Petersen FB, Clark JG. Mechanical ventilation after bone marrow transplantation. Risk factors and clinical outcome. Am Rev Respir Dis 1988; 137: 682-687.
16. Denardo SJ, Oye RK, Bellamy PE. Efficacy of intensive care for bone marrow transplant patients with respiratory failure. Crit Care Med 1989; 17: 4-6.
17. Snow RM, Miller WC, Rice DL, Ali MK. Respiratory failure in cancer patients. JAMA 1979; 241: 2039-2042.
18. Brunet F, Lanore JJ, Dhainaut JF et al. Is intensive care justified for patients with haematological malignancies? Intensive Care Med 1990; 16: 291-297.
19. Schuster DP, Marion JM. Precedents for meaningful recovery during treatment in a medical intensive care unit. Outcome in patients with hematologic malignancy. Am J Med 1983; 75: 402-408.
20. Butt W, Barker G, Walker C, Gillis J, Kilham H, Stevens M. Outcome of children with hematologic malignancy who are admitted to an intensive care unit. Crit Care Med 1988; 16: 761-764.
21. Faber-Langendoen K, Caplan AL, McGlave PB. Survival of adult bone marrow transplant patients receiving mechanical ventilation: a case for restricted use. Bone Marrow Transplant 1993; 12: 501-507.
22. Paz H, Crilley P, Weinar M, Brodsky I. Outcome of patients requiring medical ICU admission following bone marrow transplantation. Chest 1993; 104: 527-531.
23. Chaflin DB, Carlon GC. Age and utilization of intensive care unit resources of critically ill cancer patients. Crit Care Med 1990; 18: 694-698.
24. Sculier JP, Ries F, Verboven N, Coune A, Klastersky J. Role of intensive care unit in a medical oncology department. Eur J Cancer Clin Oncol 1988; 24: 513-517.
25. Sculier JP, Markiewicz E. Medical cancerpatients and intensive care. Anticancer Res 1991; 11: 2171-2174.
26. Carlon GC. Admitting cancer patients to the intensive care unit. Crit Care Clin 1988; 4: 183-191.
27. Rubenfeld GD, Crawford SW. Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: A case for evidence-based guidelines. Ann Intern Med 1996; 125: 625-633.
28. Sculier JP. Intensive care in the treatment of cancer patients. Curr Opin Oncol 1991; 3: 656-662.
29. Azoulay E, Recher C, Alberti C et al. Changing use of intensive care for hematological patients: the example of multiple myeloma. Intensive Care Med 1999; 25: 1395-1401.
30. Groeger JS, White P Jr, Nierman DM et al. Outcome for cancer patients requiring mechanical ventilation. J Clin Oncol 1999; 17: 991-997.
31. Sculier JP, Paesmans M, Markiewicz F, Berghmans T. Scoring systems in cancer patients admitted for an acute complication in a medical intensive care unit. Crit Care Med 2000; 28: 2786-2792.
32. Afessa B, Tefferi A, Dunn WF, Litzow MR, Peters SG. Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients. Crit Care Med 2003; 31: 1715-1721.
33. Kroschinsky F, Weise M, Illmer T et al. Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies. Intensive Care Med 2002; 28: 1294-1300.
34. Benoit DD, Vandewoude KH, Decruyenaere JM, Hoste EA, Colardyn FA. Outcome and early prognostic indicators in patients with hematologic malignancy admitted to the intensive care for a life-threatening complication. Crit Care Med 2003; 31: 104-112.
35. Soares M, Salluh JI, Spector N, Rocco JR. Characteristics and outcomes of cancer patients requiring mechanical ventilation support for more than 24 hours. Crit Care Med 2005; 33: 520-526.
36. Azoulay E, Alberti C, Bornstain C et al. Improved survival in cancer patients requiring mechanical ventilatory support: impact of non-invasive mechanical ventilatory support. Crit Care Med 2001; 29: 519-525.
37. Larche J, Azoulay E, Fieux F et al. Improved survival of critically ill cancer patients with septic shock. Intensive Care Med 2003; 29: 1688-1695.
38. Moran JL, Solomon PJ, Williams PJ. Assessment of outcome over a 10-year period of patients admitted to a multidisciplinary adult intensive care unit with haematological and solid tumours. Anaesth Intensive Care 2005; 33: 26-35.
39. Danai PA, Moss M, Mannino DM, Martin GS. The epidemiology of sepsis in patients with malignancy. Chest 2006; 129: 1432-1440.
40. Khassawneh BY, White P Jr, Anaissie EJ, Barlogie B, Hiller FC. Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation. Chest 2002; 121: 185-188.
41. Hilbert G, Gruson D, Vargas F et al. Non-invasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001; 344: 481-487.
42. Afessa B, Tefferi A, Litzow MR, Peters SG. Outcome of diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med 2002; 166: 1364-1368.
43. Azoulay E, Fieux F, Moreau D et al. Acute monocytic leukemia presenting as acute respiratory failure. Am J Respir Crit Care Med 2003; 167: 1329-1333.
44. Wössmann W, Schrappe M, Meyer U, Zimmermann M, Reiter A. Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/ leukemia before and after introduction of prophylactic use of urate oxidase. Ann Hematol 2003; 82: 160-165.
45. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342: 1301-1308.
46. Rivers E, Nguyen B, Havstad S et al. Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-1377.
47. Azoulay E, Pochard F, Chevret S et al. PROTOCETIC Group. Compliance with triage to intensive care recommendations. Crit Care Med 2001; 29: 2132-2136.
48. Garrouste-Orgeas M, Montuclard L, Timsit JF et al. French ADMISSIONREA Study Group. Predictors of intensive care unit refusal in French intensive care units: a multiple-center study. Crit Care Med 2005; 33: 750-755.
49. Azoulay E, Moreau D, Alberti C et al. Predictors of short-term mortality in critically ill patients with solid malignancies. Intensive Care Med 2000; 26: 1817-1823.
50. Abbas FM, Sert MB, Rosenshein NB, Zahyrak ML, Currie JL. Gynecologic oncology patients in the surgical ICU. Impact on outcome. J Reprod Med 1997; 42: 173-178.
51. Leath CA 3rd, Kendrick JE 4th, Numnum TM et al. Outcomes of gynecologic oncology patients admitted to the intensive care unit following surgery: A university teaching hospital experieace. Int J Gynecol Cancer 2006; 16: 1766-1769.
52. Blot F, Guiguet M, Nitenberg G, Leclerq B, Gachot B, Escudier B. Prognostic factors for neutropenic patients in an intensive care unit: respective roles of underlying malignancies and acute organ failures. Eur J Cancer 1997; 33: 1031-1037.
53. Massion PB, Dive AM, Bulpa P, Jamart J, Bolsy A, Installe E. Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med 2002; 30: 2260-2270.
54. Darmon M, Azoulay E, Alberti C et al. Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients. Intensive Care Med 2002; 28: 1775-1780.
55. Vallot F, Paesmans M, Berghmans T, Sculier JP. Leucopenia is an independent predictor in cancer patients requiring invasive mechanical ventilation: a prognostic factor analysis in a series of 168 patients. Support Care Cancer 2003; 11: 236-241.
56. Regazzoni CJ, Irrazabal C, Luna CM, Poderoso JJ. Cancer patients with septic shock: mortality predictors and neutropenia. Support Care Cancer 2004; 12: 833-839.
57. Epner DE, White P, Krasnoff M, Khanduja S, Kimball KT, Knaus WA. Outcome of mechanical ventilation for adults with hematologic malignancy. J Investig Med 1996; 44: 254-260.
58. Azoulay E, Thiery G, Chevret S et al. The prognosis of acute respiratory failure in critically ill cancer patients. Medicine 2004; 83: 360-370.
59. Depuydt PO, Benoit DD, Vandewoude KH, Decruyenaere JM, Colardyn FA. Outcome in noninvasively and invasively ventilated hematologic patients with acute respiratory failure. Chest 2004; 126: 1299-1330.
60. Boussat S, Elrini T, Dubiez A, Depierre A, Barale F, Capellier G. Predictive factors of death in primary lung cancer patients on admission to the intensive care unit. Intensive Care Med 2000; 26: 1811-1816.
61. Rabbat A, Chaoui D, Montani D et al. Prognosis of patients with acute myeloid leukaemia admitted to intensive care. Br J Haematol 2005; 129: 350-357.
62. Groeger JS, Lemeshow S, Price K et al. Multicenter outcome study of cancer patients admitted to the intensive care unit: a probability of mortality model. J Clin Oncol 1998; 16: 761-770.
63. Soares M, Carvalho MS, Salluh JI et al. Effect of age on survival of critically ill patients with cancer. Crit Care Med 2006; 34: 912-923.
64. Soares M, Salluh JI, Toscano L, Dias FL. Outcomes and prognostic factors in patients with head and neck cancer and severe acute illnesses. Intensive Care Med 2007; 33: 2009-2013.
65. Christodoulou C, Rizos M, Galani E, Rellos K, Skarlos DV, Michalopoulos A. Performance status (PS): a simple predictor of short-term outcome of cancer patients with solid tumors admitted to the intensive care unit (ICU). Anticancer Res 2007; 27: 2945-2948.
66. Guiguet M, Blot F, Escudier B, Antoun S, Leclercq B, Nitenberg G. Severity-of-illness scores for neutropenic cancer patients in an intensive care unit: Which is the best predictor? Do multiple assessment times improve the predictive value? Crit Care Med 1998; 26: 488-493.
67. Blot F, Cordonnier C, Buzin A, Nitenberg G, Schlemmer B, Bastuji-Garin S. Club sur L'Infection en Onco-Hematologie. Severity of illness scores: are they useful in febrile neutropenic adult patients in hematology wards? A prospective multicenter study. Crit Care Med 2001; 29: 2125-2131.
68. Headley J, Theriault R, Smith TL. Independent validation of APACHE II severity of illness score for predicting mortality in patients with breast cancer admitted to the intensive care unit. Cancer 1992; 70: 497-503.
69. Van Le L, Fakhry S, Walton LA, Moore DH, Fowler WC, Rudledge R. Use of the APACHE II scoring system to determine mortality of gynecologic oncology patients in the intensive care. Obstet Gynecol 1995; 85: 53-56.
70. Soares M, Salluh JI. Validation of the SAPS 3 admission prognostic model in patients with cancer in need of intensive care. Intensive Care Med 2006; 32: 1839-1844.
71. Thiery G, Azoulay E, Darmon M et al. Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol 2005; 23: 4406-4413.
72. den Boer S, de Keizer NF, de Jonge E. Performance of prognostic models in critically ill cancer patients-a review. Crit Care 2005; 9: R458-463.
73. Soares M, Fontes F, Dantas J et al. Performance of six -of-illness scores in cancer patients requiring admission to the intensive care unit: a prospective observational study. Crit Care 2004; 8: R194-R203.
74. Groeger JS, Glassman J, Nierman DM et al. Probability of mortality of critically ill cancer patients at 72 h of intensive care unit (ICU) management. Support Care Cancer 2003; 11: 686-695.
75. Berghmans T, Paesmans M, Sculier JP. Is a specific oncological scoring system better at predicting the prognosis of cancer patients admitted for an acute medical complication in an intensive care unit than general gravity scores? Support Care Cancer 2004; 12: 234-239.
76. Schellongowski P, Benesch M, Lang T et al. Comparison of three severity scores for critically ill cancer patients. Intensive Care Med 2004; 30: 430-436.
77. Cornet AD, Issa AI, van de Loosdrecht AA et al. Sequential organ failure predicts mortality of patients with a haematological malignancy needing intensive care. Eur J Haematol 2005; 74: 511-516.
78. Soares M, Darmon M, Salluh JI et al. Prognosis of lung cancer patients with life-threatening complications. Chest 2007; 131: 840-846.
79. Timsit JF, Fosse JP, Troche G et al. Accuracy of a composite score using daily SAPS II and LOD scores for predicting hospital mortality in ICU patients hospitalized for more than 72 h. Intensive Care Med 2001; 27: 1012-1021.
80. Afessa B, Keegan MT, Mohammad Z, Finkielman JD, Peters SG. Identifying potentially ineffective care in the sickest critically ill patients on the third ICU day. Chest 2004; 126: 1905-1909.
81. Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL. Serial evaluations of the SOFA score to predict outcome in critically ill patients. JAMA 2001; 286: 1754-1758.
82. Pène F, Aubron C, Azoulay E et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol 2006; 24: 643-649.
83. Lecuyer L, Chiery G, Darmon M, Schlemmer B, Azoulay E. The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med 2007; 35: 808-814.
84. Azoulay E, Schlemmer B. Diagnostic strategy in cancer patients with acute respiratory failure. Intensive Care Med 2006; 32: 808-822.
85. Lanore JJ, Brunet F, Pochard F et al. Hemodialysis for acute renal failure in patients with hematologic malignancies. Crit Care Med 1991; 19: 346-351.
86. Berghmans T, Meert AP, Markiewicz E, Sculier JP. Continuous venovenous haemofiltration in cancer patients with renal failure: a single-centre experience. Support Care Cancer 2004; 12: 306-311.
87. Benoit DD, Hoste EA, Depuydt PO et al. Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies. Nephrol Dial Transplant 2005; 20: 552-558.
88. Darmon M, Thiery G, Ciroldi M, Porcher R, Schlemmer B, Azoulay E. Should dialysis be offered to cancer patients with acute kidney injury? Intensive Care Med 2007; 33: 765-772.
89. Soares M, Salluh JI, Carvalho MS. Darmon M, Rocco JR, Spector N. Prognosis of critically ill patients with cancer and acute renal dysfunction. J Clin Oncol 2006; 24: 4003-4010.
90. Torrecilla C, Cortes JL, Chamorro C, Rubio JJ, Galdos P, Dominguez de Villota E. Prognostic assessment of the acute complications of bone marrow transplantation requiring intensive therapy. Intensive Care Med 1988; 14: 393-398.
91. Crawford SW, Petersen FB. Long-term survival from respiratory failure after marrow transplantation for malignancy. Am Rev Respir Dis 1992; 145: 510-514.
92. Hollmig KA, Soehngen D, Leschke M et al. Long-term survival of recipients of allogenic bone-marrow transplantation after mechanical ventilation. Eur J Med Res 1997; 2: 62-66.
93. Kantrow SP, Hackman RC, Boeckh M, Myerson D, Crawford SW. Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation. Transplantation 1997; 63: 1079-1086.
94. Shorr AF, Moores LK, Edenfield WJ, Christie RJ, Fiitzpatrick TM. Mechanical ventilation in hematopoietic stem cell transplantation: can we effectively predict outcomes? Chest 1999; 116: 1012-1018.
95. Huaringa AJ, Leyva FJ, Giralt SA et al. Outcome of bone marrow transplantation patients requiring mechanical ventilation. Crit Care Med 2000; 28: 1014-1017.
96. Soubani AO, Kseibi E, Bander JJ et al. Outcome and prognostic factors of hematopoietic stem cell transplantation recipients admitted to a medical ICU. Chest 2004; 126: 1604-1611.
97. Bach PB, Schrag D, Nierman DM et al. Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation. Blood 2001; 98: 3234-3240.
98. Ferra C, Marcos P, Misis M et al. Outcome and prognostic factors in patients with hematologic malignancies admitted to the intensive care unit: a single-center experience. Int J Hematol 2007; 85: 195-202.
99. Darmon M, Thiery G, Giroldi M et al. Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy. Crit Care Med 2005; 33: 2488-2493.
100. Benoit DD, Depuydt PO, Vandewoude KH et al. Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit. Intensive Care Med 2006; 32: 93-99.
101. Jennens RR, Rosenthal MA, Mitchell P, Presneill JJ. Outcome of patients admitted to the intensive care unit with newly diagnosed small cell lung cancer. Lung Cancer 2002; 38: 291-296.
102. Tanvetyanon T. Consideration before administering cytotoxic chemotherapy to the critically ill. Crit Care Med 2005; 33: 2689-2691.
103. Marik PE. Management of patients with metastatic malignancy in the intensive care unit. Am J Hospice and Palliative Medicine 2007; 23: 479-482.
104. Reisfield GM, Wallace SK, Munsell MF, Webb FJ, Alvarez ER, Wilson GR. Survival in cancer patients undergoing in-hospital cardiopulmonary resuscitation: a meta-analysis. Resuscitation 2006; 71: 152-160.
105. Wallace SK, Ewer MS, Price KJ, Feeley TW. Outcome and cost implications of cardiopulmonary resuscitation in the medical intensive care unit of a comprehensive cancer center. Support Cancer Care 2002; 10: 425-429.
106. Saklayen M, Liss H, Markert R. In-hospital cardiopulmonary resuscitation. Survival in 1 hospital and literature review. Medicine 1995; 74: 163-175.
107. Carlet J, Thijs LG, Antonelli M et al. Challenges in end-of-life care in the ICU. Statement of the 5th International Consensus Conference in Critical Care: Brussels, Belgium, April 2003. Intensive Care Med 2004; 30: 770-784.
108. Withholding and withdrawing life-sustaining therapy. Official Statement of the American Thoracic Society. Am Rev Respir Dis 1991; 144: 726-731.
109. Nelson JF, Meier DE, Oei EJ et al. Self-reported symptom experience of critically ill patients receiving intensive care. Crit Care Med 2001; 29: 277-282.
110. Fried TR, Bradley EH, Towle VR, Allore H. Understanding the treatment preferences of seriously ill patients. N Engl J Med 2002; 346: 1061-1066.
111. Sprung CL, Cohen SL, Sjokvist P et al. Ethicus Study Group. End-of-life practices in European intensive care units: the Ethicus Study. JAMA 2003; 290: 790-797.
112. Sprung CL, Woodcock T, Sjokvist P et al. Reasons, considerations, difficulties and documentation of end-of-life decisions in European intensive care units: the ETHICUS Study. Intensive Care Med 2007 Nov 9.